Because calcineurin inhibitor (CNI) immunosuppressive drugs induce arteriolar hyalinosis (ah) in kidney transplants, ah lesions can potentially provide information about drug exposure. We studied the relationship of ah lesions to findings and outcomes in 562 indication biopsies taken 3 days to 35 years after transplant. Prevalence of ah lesions increased with time of biopsy after transplant (TxBx). The ah scores correlated with arterial intimal thickening and atrophy-fibrosis but, unlike atrophy-fibrosis, did not increase until after 500 days because of a background of ah1 lesions in early biopsies reflecting donor aging. Correlation of ah scores with other features varied with TxBx-in early biopsies, donor age and related changes, and in very late biopsies, chronic antibody-mediated rejection and glomerulonephritis and associated lesions. After correction for TxBx, ah0 in intermediate time periods was associated with increased risk of T cell-mediated rejection and graft loss, probably because of underimmunosuppression and nonadherence. Thus, ah lesions in indication biopsies have multiple associations: donor age (early, usually ah1), chronic glomerular diseases (late, often ah2/3), and adequate exposure to CNIs at intermediate times. This threefold TxBx-dependent complexity must be considered when interpreting indication biopsies: ah lesions often indicate adequate CNI exposure, not toxicity, and unexpected ah0 should increase vigilance for nonadherence and underimmunosuppression.
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Introduction
Afferent arteriolar hyalinosis (ah) in kidneys has complex associations with renal aging and other conditions such as hypertension (1, 2) , diabetes (3, 4) , and progressive renal diseases (5) , as well as calcineurin inhibitor (CNI) immunosuppressive drugs (6, 7) , but the latter has dominated the literature in transplantation. Since the early days of CNI immunosuppression, nephrotoxicity has been identified as a major side effect (8) (9) (10) , with ah being the most characteristic lesion (11) . CNIs induce ah lesions in native kidneys (12) (13) (14) (15) as well as in kidney transplants (8) (9) (10) over time and are regarded as a change that eventually affects most kidneys with increasing duration of CNI exposure (6, 7, 16, 17) . Although some investigators have tried to develop criteria that distinguish CNI ah lesions from other causes (18, 19) , the usual scoring system simply grades ah lesions as 0-3 without inferring causality (20) , with only moderate interobserver agreement (19, 21, 22) . Often, ah lesions are associated with other lesions related to scarring-interstitial fibrosis (ci scores), tubular atrophy (ct scores), and arterial fibrous intimal thickening (cv scores) (23)-although this is largely due to the association of all of these lesions with advancing time of biopsy after transplant (TxBx). Although ah lesions are correlated with atrophy-fibrosis, they have different relationships to graft loss, with lack of ah lesions (ah0) as a potential risk factor for graft loss (24) (25) (26) . This suggests that the ah0 score may, at times, indicate inadequate drug exposure and nonadherence.
The present study was initiated to better understand the significance of ah lesions in indication biopsies and their relationship to adherence and to other histologic and clinical features (e.g. donor age, rejection, scarring, TxBx, and risk of graft loss).
Methods
Patient population, specimens, and data collection Kidney transplant biopsies (n = 703) were collected in two consecutive prospective multicenter studies of 562 consented patients: 403 biopsies from the Genome Canada study and 300 from INTERCOM (ClinicalTrials. gov NCT01299168) (27) (28) (29) (30) . Patients were consented under protocols approved by local institutional review boards. To be enrolled, patients had to have biopsies suitable for histology reporting and microarray analysis. Every biopsy was included so as to represent all injury and disease states commonly affecting kidney transplants (28) . In total, 102 patients had more than one biopsy during the study period. For those patients, we randomly selected one biopsy for our analysis, resulting in 562 biopsies used for this study. Although the analyses we report are based on the first randomly generated set of 562 biopsies, examination of additional randomizations and of all first biopsies and all last biopsies showed that the results were always qualitatively the same, producing the same conclusions and differing little quantitatively.
Biopsy assessment
Details of conventional biopsy assessment have been published (27) (28) (29) (30) . Biopsy processing was performed as standard of care for the center. The biopsies were assessed by local pathologists, according to the principles of the Banff system (20, 31) . Accordingly, the criteria for ah lesion scoring were as follows: ah0: no typical lesions of arteriolopathy; ah1: replacement of degenerated smooth muscle cells by hyaline deposits present in only one arteriole, no circumferential involvement; ah2: replacement of degenerated smooth muscle cells by hyaline deposits present in more than one arteriole but no circumferential involvement; ah3: replacement of degenerated smooth muscle cells by hyaline deposits with circumferential involvement, independent of the number of arterioles involved (20) . All biopsies have been classified to reflect the latest update of the Banff guidelines, particularly the Banff 2007 guidelines for T cell-mediated rejection (TCMR) (20) and the Banff 2013 guidelines (31) acknowledging the existence of C4d-negative antibody-mediated rejection (ABMR) and of intimal arteritis (v score) lesions in ABMR.
HLA antibody testing at biopsy was recommended in the study, but the decision to perform it and the method were determined by local standard of care. Antibody specificities were usually determined either by LABScreen or FlowPRA single-antigen beads (One Lambda, Canoga Park, CA). No testing was reported for 75 cases, and donor-specific antibody (DSA) was not reported in 11 patients positive for panel reactive antibody.
Statistical analysis
Data analyses were performed using R version 3.2.3 (R Foundation for Statistical Computing, Vienna, Austria). Spearman correlations, chi-square tests, and nonparametric t-tests were used to compare variables, as indicated in the tables. The relationship between histologic features and graft loss was assessed using Cox regression.
Some figures illustrate the relationship between lesion scores and TxBx using a moving average. The first element of the moving average is obtained by plotting the average of the lesion scores of the first (i.e. earliest) 100 biopsies against the average TxBx of the first 100 biopsies. The earliest biopsy's data is then replaced by the 101st, and the plotting point is recalculated. This process is repeated over the entire data series, with the line connecting all averages being the moving average. The same method was used to illustrate the change in correlation between the ah lesion score and other histologic and clinical variables over time, as well as for assessing the proportion of graft failures in relationship to ah score and time.
Results

Demographics
Patient demographics are shown in Table 1 . This analysis of prospectively collected biopsies from consented patients was focused on ah lesions, not CNIs per se, so every patient with available data was included, even those not on CNIs at the time of biopsy. Almost all biopsies were from patients (96%) on CNIs at some time, with 92% on CNIs at the time of biopsy. Those recorded as not being on CNIs at the time of biopsy had usually been taken off CNIs for clinical reasons (e.g. polyoma virus nephropathy). The distribution of ah lesions in patients not on CNIs was identical to those not on CNIs. In our opinion, excluding the 4% of biopsies from patients with no recorded exposure to CNIs would not significantly affect the results.
As a multicentered cross-sectional study that included patients up to 35 years after transplant, detailed information on CNI exposure was either unavailable or unreliable. Moreover, recorded CNI exposure has little relationship to histologic changes in biopsies (17, 32) .
The presence of ah lesions (ah>0 vs. ah0) was strongly associated with TxBx (p < 0.0001) ( Table 1) . Proteinuria, DSA, and non-donor-specific HLA antibodies were more frequent in biopsies with ah>0, and the fraction of biopsies with ah>0 was higher for patients on cyclosporine regimens than on tacrolimus regimens (p = 0.000024). This was in part due to the greater TxBx for patients on cyclosporine versus those on tacrolimus (1580 and 1071 days, respectively), although the difference was of only borderline significance (p = 0.06).
The increase in mean ah lesion scores over TxBx differs from that of atrophy and fibrosis The ah lesions in the entire biopsy population correlated with TxBx (Spearman correlation coefficient r = 0.534, p < 0.0001), like atrophy-fibrosis lesions (33) (Figure 1A) , with low mean ah scores in early biopsies (<3 mo) and high mean ah scores in late biopsies (>3 years). Although mean atrophy and fibrosis scores (shown as ci and ct scores) increased steadily with log TxBx, the mean ah scores showed a different pattern, remaining low in the intermediate period followed by a steep rise in the period after %500 days.
Ah0 was frequent in early biopsies but rare in biopsies taken >5 years after transplant ( Figure 1B ). Ah1 lesion scores showed two peaks. They were common (30%) in early biopsies, probably reflecting donor age; became less frequent in biopsies between 3 mo and 3 years after transplant; were frequent in biopsies taken between 3 and 10 years after transplant; and were almost absent in biopsies >10 years after transplant. In contrast, the prevalence of ah2 and ah3 was low in early biopsies and increased after 3 years with increasing TxBx.
The lower frequency of ah1 lesions in the intermediate time interval compared with early biopsies could reflect differences in case mix. Grafts with biopsies in the early and intermediate time intervals were similar regarding donor age (44.4 AE 13.8 vs. 44.4 AE 14.3), proportion of donors aged >60 years (12% vs. 14%), deceased donors (56% vs. 44%), and deceased donors aged >60 years (9.6% vs. 12.3%). The diagnoses, however, differ between these two groups. In the early time interval, the majority of biopsies showed histologic signs of acute kidney injury (AKI; 39%) or no significant histologic findings (20%); 32% had a diagnosis of TCMR or borderline, and only 3% had a diagnosis of ABMR. In the intermediate time period, the incidence of TCMR or borderline was similar (32%), but no biopsy in the intermediate period was diagnosed as AKI, whereas the incidence of ABMR was higher (19%) compared with the early biopsies. Overall, 21 patients with biopsies in the early time interval (0-3 mo) had repeat biopsies in the intermediate time interval (3 mo to 3 years). Eleven of these patients had ah lesion scores >1 in the early biopsy (i.e. probably donor-derived ah). One of the patients had progression from ah1 to ah2 in the second biopsy, one had unchanged ah lesion scores (ah1), the other nine patients showed reduction in the ah lesion score in the second biopsy. The average lesion score of these 21 patients was 0.76 AE 0.89 in the first biopsies (i.e. early interval) and 0.57 AE 0.75 in the second biopsies (i.e. intermediate interval). Consequently, our data suggests some degree of reversibility of donor-derived ah lesions. This difference, however, was not statistically significant (p = 0.33), possibly because of the small number of patients with repeat biopsies in these specific time intervals. Associations of ah lesion scores with other histology lesions Across the entire time course, the ah score correlated with TxBx (r = 0.54), double contours (cg score; r = 0.40), and mesangial matrix (mm score; r = 0.40) ( Table 2 ). Weaker correlations (<0.40) were noted for glomerulitis (g score; r = 0.24), cv score (r = 0.35), ci score (r = 0.31), and ct score (r = 0.29).
Because many features are correlated with TxBx, apparent associations between variables could simply reflect their mutual relationship to TxBx. Consequently, relationships were reanalyzed within intervals (early, 0-3 mo; intermediate, 3 mo to 3 years; and late, >3 years) ( Table 2 ) and as rolling average correlations over time (Figure 2 ).
The only association with ah scores that persisted across the time intervals was that with the cv score (early, r = 0.35; intermediate, r = 0.31; and late, r = 0.30), suggesting a robust relationship between arteriolar and arterial changes independent of TxBx ( Table 2 ).
The associations of the ah score with other features varied with TxBx, probably reflecting the multiple causes of ah lesions. In early biopsies, the ah score correlated with donor age, tubular atrophy, and interstitial fibrosis, but this association disappeared in the intermediate and late periods (Table 2) . Within early biopsies, ah was not related to TxBx, as expected if these lesions reflected donor aging.
In the intermediate interval, there was a weak association of the ah score with double contours (cg score). (Table 2 ).
In late biopsies, ah scores were associated with peritubular capillaritis (ptc score) and with lesions of chronic glomerular diseases (cg score, mm score, and g score) ( Table 2) , probably reflecting the prominence of ABMR with cg lesions and glomerulonephritis (GN) in late biopsies. Tubulitis (t score) showed a weak negative correlation with ah scores, but this correlation was lost when considering TxBx.
The rolling average correlations of ah scores with other features are shown in Figure 2 . In Figure 2 (A), donor age correlates only in the early period. The cv score has two peaks of correlation with ah score: the first in early and intermediate biopsies <3 years after transplant and a second peak in biopsies >5 years, probably reflecting different etiologies of the cv lesion in early (donor aging) and late (new-onset lesions, perhaps reflecting chronic diseases, e.g. ABMR and GN as well as interstitial fibrosis and tubular atrophy [IFTA]). In Figure 2 (B), the lesions of ABMR and chronic glomerular diseases (cg, g, mm, and ptc scores) correlate mainly in the late period. In Figure 2 (C), the lesions associated with TCMR (interstitial inflammation [i], t, and v scores) showed weak anticorrelations with ah scores in the early and intermediate periods (not significant), probably related to the association of TCMR diagnoses with ah0, as discussed subsequently.
Associations of ah lesion scores with histologic diagnoses As shown in Table 3 , the distribution of ah0 versus ah>0 was not the same across all biopsy diagnoses (chi-square contingency test, p = 3 9 10 À10 ). Most biopsies with a diagnosis of TCMR, BK virus, or AKI (76%, 89%, and To capture the changing relationship between the ah score and other features over time (see Table 2 ), this graph shows the moving average correlation. We assessed the correlation between ah score and donor age, tubular atrophy, interstitial fibrosis, and fibrous intimal thickening (A), the relationship between ah score and glomerular lesions (glomerulitis, mesangial matrix increase, double contours) as well as peritubular capillaritis (B), and the relationship between ah scores and lesions of T cell-mediated rejection (tubulitis, interstitial inflammation, and intimal arteritis) (C). ah, arteriolar hyalinosis; Tx, transplant. 67%, respectively) had no hyalinosis (ah0). TCMR and borderline rejection were rare in biopsies with ah2 or ah3. However, ah0 per se did not predict TCMR risk overall: Most of the 220 biopsies with ah0 did not have TCMR or borderline.
In contrast, most biopsies with chronic glomerular disease (ABMR or GN) had ah>0 (75% and 66%, respectively). ABMR was subphenotyped on the basis of its lesions, creating three subphenotypes: pgABMR (with ptc or g lesions but no cg), pgcgABMR (with ptc or g lesions and cg lesions), and cgABMR (with cg but no ptc or g lesions) (34) . ABMR with high ah scores was seen mainly in ABMR with cg lesions: 88% of pgcgABMR and 83% of cgABMR had ah>0, in most cases ah2 or ah3. In contrast, pgABMR showed no association with ah scores (50% ah0, 50% ah>0).
Most biopsies with ah3 were diagnosed with a specific disease, mostly (46 of 70) chronic glomerular diseases: ABMR with cg lesions, mixed ABMR/TCMR, or GN. Biopsies with atrophy-fibrosis but no disease diagnosis (e.g. IFTA) had no association with ah scores; they were distributed evenly across scores of ah0 (22 of Because of the strong influence of TxBx on ah, we used logistic regression to see which diagnoses were significantly associated with ah>0 when log10 (TxBx) was used as a covariate. Significant associations were found for BK virus (p = 0.006), TCMR (p = 0.01), and ABMR with cg lesions (cgABMR and pgcgABMR) (p = 0.02). After correcting for TxBx, a diagnosis of TCMR or BK virus was associated with ah0, whereas a diagnosis of ABMR with cg was associated with ah>0.
The presence of ah lesions is associated with benefit for graft survival when correcting for time The ah3 lesions were associated with graft loss when all biopsies were analyzed ( Figure 3A) ; however, this is misleading. The ah lesions are strongly associated with TxBx, and late biopsies carry a much higher risk of graft loss than early biopsies (24); therefore, analysis of the association of ah scores with graft loss has to take TxBx into account. The relationship between 5-year postbiopsy graft survival and TxBx, stratified by ah scores and corrected for TxBx, is shown in Figure 3 (B). The probability of the graft surviving 5 years after biopsy was lower in patients with ah0 compared with patients with ah>0.
The colored ticks at the bottom and top of Figure 3 (B) represent all biopsies (bottom) and biopsies followed by kidney failure within 5 years (top), colored by ah score, with black ticks representing biopsies with ah0. Indication biopsies with ah0 were common in the first 3 years (black ticks at the bottom of Figure 3B ). The biopsies with ah0 that proceeded to failure within 5 years (black ticks at the top of Figure 3B ) were clustered around 365 to 1000 days after transplant, when nonadherence is common. The biopsies with ah2 and ah3 (blue and red in Data are shown as number (percentage). ah scores are given for all ABMR biopsies, as well as subdivided into ABMR subcategories (italicized). ABMR, antibody-mediated rejection; ah, arteriolar hyalinosis; AKI, acute kidney injury; cgABMR, antibody-mediated rejection with double contours but no peritubular capillaritis or glomerulitis lesions; GN, glomerulonephritis; IFTA, interstitial fibrosis and tubular atrophy; NOMOA, no major abnormalities; pgABMR, antibody-mediated rejection with peritubular capillaritis or glomerulitis lesions but no double contours; pgcgABMR, antibody-mediated rejection with peritubular capillaritis or glomerulitis lesions and double contours; TCMR, T cell-mediated rejection. 1 Overall, 38 biopsies with missing ah lesion scoring and three biopsies with histologic ABMR diagnosis but no ABMR lesions were omitted. Figure 3B ) and the failures after such biopsies were more common late, >3000 days, when ABMR with cg lesions and GN is common.
Within 5 years of biopsy, 39 failures were observed in grafts with ah0, 50% of them after a diagnosis of rejection, often related to ABMR (pgABMR, n = 8; pgcgABMR, n = 5; cgABMR, n = 2; borderline, n = 3; TCMR, n = 2). Of the 34 graft failures within 6 mo after biopsy, 15 occurred in grafts with ah0; the majority of these had a diagnosis of rejection (pgABMR, n = 3; cgABMR, n = 2; pgcgABMR, n = 3; borderline, n = 1).
Using multivariable Cox regression (Table 4) with TxBx and ah (as a categorical variable with 0 as the reference level) as predictors, the effect of ah lesions on graft survival was significant, albeit small compared with TxBx. Noteworthy is the direction of the association: The hazard ratios for ah1, ah2, and ah3 were <1.0, indicating that the presence of ah lesions carries a small but significant benefit for graft survival when TxBx is taken into account. In summary, normal arterioles after the first year after transplant indirectly reflect a lack of protection through adequate immunosuppression, resulting in higher risk of graft loss compared with grafts with ah>0.
Discussion
We studied the patterns of hyalinosis and associated histologic lesions, diagnoses, and clinical features in a sample of indication biopsies taken from experienced transplant centers to determine the significance of the hyalinosis lesion in relationship to rejection, atrophy scarring, and time after transplant. Ah lesions were frequent, being present in 303 of 562 biopsies (54%). Almost all of these patients were taking or had been exposed to CNI drugs; therefore, CNI exposure cannot be used as a variable in our analysis but undoubtedly contributes to the ah lesions accumulating over time. The mean ah lesion score increased with TxBx, but it differed from atrophy scarring (ci and ct scores), lagging behind and actually falling in the intermediate period (about 2 years after transplant). Within TxBx intervals, the dominant correlations with ah changed: In early biopsies, dominant correlations were with ci and ct scores, donor age, and cv lesions; in the intermediate interval, with TxBx itself but with no strong lesion associations; and within the late biopsies, with glomerular lesions and diagnoses of glomerular diseases. Score ah3 was strongly associated with late ABMR with cg lesions and with GN, whereas ah0 was associated with TCMR. The ah lesions had a weak protective effect against death-censored graft loss.
These findings indicate that we should not infer from ah lesions in indication biopsies that CNI "toxicity" is the cause of graft deterioration but rather that they support the concept that the appearance of ah lesions is an expected consequence of adequate exposure to CNI immunosuppressive drugs over time. Moreover, in CNI-treated patients presenting with indications for biopsy, ah0 after months or years sometimes indicates underimmunosuppression and possible nonadherence, whereas advanced ah lesions often are associated with chronic glomerular diseases such as ABMR with cg lesions and GN, not CNI toxicity.
The change in mean ah score over the first years after transplantation differs markedly from the change in fibrosis and atrophy: mean ci and ct scores increase continuously over log TxBx, whereas ah has relatively a high but stable background (ah1 scores) during the first 500 days and then increases with TxBx. Scarring develops over time with the cumulative burden of injury and disease (33) , but the ah score is more complex. Ah lesions, particularly ah1, reflect donor aging in early indication biopsies. In the intermediate period, the cumulative timedependent effects of CNI immunosuppression should be apparent in adherent patients, reflected by the increase in mean ah scores after %500 days. The initial decrease in mean ah scores in the intermediate time period may reflect differences in subsets of patients being biopsied in the different time intervals: Early biopsies showed a high proportion of AKI or no significant histologic findings and thus probably represent troubled donor kidneys with slow initial function, whereas biopsies in the intermediate period had no AKI but higher rates of rejection. Based on repeat biopsies, our data suggest reversibility of donorderived ah lesions in some of our patients that could also contribute to the drop in mean ah scores in the intermediate interval. High ah scores in biopsies after 3 years are strongly associated with chronic glomerular diseases (35) , independent of CNI exposure (6,7), contributing to the rise of ah scores in the late time intervals. It is quite possible that the stress of ABMR on the endothelium induces fibrous intimal thickening (FIT) in arteries and ah in arterioles, but based on our data we cannot actually prove that FIT and ah are more likely to occur in ABMR than in other chronic glomerular diseases. Alternatively, these could be nonspecific features of kidneys undergoing nephron damage, possibly related to an increased incidence of hypertension in patients with chronic glomerular lesions. The increasing correlation of the ah score with cv (but not with ci, ct, or donor age) in late biopsies would be consistent with this explanation.
Misinterpretation of ah lesions has probably seriously affected patient management. The association of the ah score with chronic glomerular diseases in late biopsies has been underestimated previously because of two errors-the assumption that ah lesions always reflect CNI drug toxicity and the failure to recognize C4d-negative ABMR (11)-resulting in the interpretation of ah3 lesions in deteriorating late kidney transplants as CNI drug toxicity. When most ABMR could not be recognized because the histology consensus insisted that C4d was required for the diagnosis, biopsies with ABMR were often diagnosed as chronic allograft nephropathy (CAN) and assumed to be caused by CNIs. Now that the extent of C4d-negative ABMR is appreciated (24) , the relationship of advanced ah lesions to chronic glomerular diseases emerges. Data drift may also have contributed:
The populations treated with higher CNI doses (predominantly with cyclosporine) in the 1990s were more prone to CNI toxicity than contemporary transplants managed with mycophenolate and lower CNI dosespredominantly with tacrolimus, as in the Symphony study (36) . Note in the present study that the fraction of biopsies with ah>0 was higher in patients on cyclosporine than on tacrolimus.
The powerful association of ah lesions with TxBx mandates that interpretation of hyalinosis must always take TxBx into account, revealing that ah0 is more of a risk for graft loss than ah>0 in a multivariate analysis. The absence of ah lesions, particularly in the intermediate period when nonadherence is a concern, carries increased risk of graft failure, consistent with our earlier analysis (24) . A recent study found that the relation between CNI exposure and progressive histological injury is poor (17) and that graft survival in the tacrolimus era is higher compared with the cyclosporine era (96% vs. 89%), despite comparable ah (17, 32) . These findings are compatible with the conclusion that ah per se seldom allows the conclusion that CNI toxicity is the cause of graft failure. This observation has clinical implications: Clinicians have been likely to reduce or discontinue CNIs when ah2 or ah3 is found in the biopsy. If ah lesions are part of ongoing active ABMR, this urge should be resisted, and CNIs should probably not be reduced under these circumstances.
The association of ah0 in indication biopsies with poor outcomes was driven by patients presenting in the intermediate period, suggesting that many of these patients prescribed CNIs for many months but, with no ah, may be nonadherent or inadequately immunosuppressed. Low immunosuppression probably also contributes to the association of ah0 with BK virus nephropathy: In many cases, immunosuppression is reduced when BK virus infection is evident by monitoring of viral load, and the biopsy is taken only when renal function deteriorates. At the time of biopsy, the patient often has had reduced immunosuppression for some time. The corollary is that ah lesions produced by CNI are a desirable finding in the intermediate period, when nonadherence and underimmunosuppression are major factors triggering TCMR and pgABMR (34) . Nevertheless, the ah0 class is heterogeneous with respect to prevalence of TCMR and graft loss, suggesting that more granular assessment of changes within the ah0 biopsies will be needed. We are currently developing molecular assessments to predict nonadherence (37) (J. Reeve et al., unpublished data, October 2016).
If TCMR does not increase the risk of future graft loss compared with other conditions in indication biopsies (38) , it seems paradoxical that ah0 is associated with increased risk of both TCMR and graft loss, but the probable link is nonadherence presenting initially as TCMR but eventually leading to DSA and pgABMR (39) . Our hypothesis is that TCMR does not directly program late graft loss but, if caused by nonadherence, sets the stage for development of DSA and pgABMR. Some evidence of this sequence has been presented by other studies (40, 41) . Consequently, graft loss from nonadherence not only may be caused by nonadherence at the time of biopsy with ah0 but also could be triggered by previous nonadherence resulting in development of DSA, perhaps presenting with ABMR years later, with ah2 and ah3 in a currently adherent patient. In other words, the total burden of nonadherence may be underestimated by the present study because a period of undetected nonadherence can trigger silent long-term ABMR.
Our study indicates (i) that ah lesions in indication biopsies have multiple associations and can seldom be interpreted as indicating that CNI toxicity is the cause of the graft deterioration and (ii) that common practice in some centers of reducing CNIs in biopsies with ah3 should be reviewed carefully. The study takes as a given that CNIs produce a time-dependent hyalinosis because this is well established in the literature. We did not have enough data on the presence or duration of continuing or posttransplant diabetes to analyze its correlation with late ah; however, from the data available, it seems at best to be a minor factor in this indication biopsy population. Our study showed that in early indication biopsies, ah lesions caused by donor aging are overrepresented (usually ah1), whereas in late biopsies, chronic glomerular diseases are common (ABMR with cg lesions and GN) in biopsies with ah2 and ah3. The latter is important to recognize because many of these biopsies with C4d-negative ABMR have likely been called CNI toxicity previously, and immunosuppression reduction may have put patients at increased risk. Moreover, TxBx correction revealed that ah0 was a risk for TCMR and for graft loss (often due to ABMR) compared with other grades of ah, both probably a consequence of nonadherence. This explains previous findings that ah0 may be a risk factor for graft loss (24) (25) (26) . In conclusion, the TxBx-dependent complexity of ah lesions-donor age, nonadherence and underimmunosuppression, and chronic glomerular disease-must now be part of interpretation of the clinical scenarios leading to indication biopsies and presents opportunities for improving management compared with reflex reduction of CNI doses when ah2 or ah3 lesions are encountered.
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